Interestingly, AAV9-Gata4-shRNA administration significantly attenuated the SASP and aggravated post-MI heart dysfunction[25], suggesting that the premature senescence of cells in the heart, including cardiomyocytes, may play a protective role in the post-MI heart. The gene discussed is GATA4; the disease is myocardial infarction.